Sentences with phrase «patent medicine company»

Set in a pair of 1895 buildings, which once included the home of the J.C. Ayer patent medicine company, the condo studios opened in 2000 along with a ground - level gallery that shows work by the residents and other local artists.

Not exact matches

A valuation of the company would involve only an appraisal of the soft stuff: the company's medicine patents and the Nature's Cure brand.

While terms like «patent protection» and «public domain» were clearly part of the IPR debate, it also stretched to the cost of drugs and the availability of medicines, encompassing terms like «health advocates» and «pharmaceutical companies.»

Drug companies often face the need to come up with new medicines, especially as patents on older pharmaceuticals expire.

Ruike and her colleagues have filed a patent on their technique and are continuing to collaborate with the medical supply company, which is currently making plans to manufacture medicine patches made from kirigami films.

Five years later, Gilead became the first pharmaceutical company to sign an agreement with the newly formed Medicines Patent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counPatent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counpatent - protected medicines so that they can be produced in generic form for low income countries.

GSK says it also plans to take a more «graduated» approach to filing and enforcing patents for other medicines to encourage generic drug companies to make and supply GSK products now available mainly in developed countries.

And according to a study by economist Roger Svensson, even though Swedish universities account for a third of all the country?s R&D, in the medicine and hygiene sectors university - related scientists and companies own only 10 % of recent patents.

In September 2013 a report on the «crisis in cancer care» from the Institute of Medicine recommended offering drug companies a patent extension of six months on new drugs that have been tested in the elderly; a similar incentive has greatly increased the testing of drugs in children.

Ruike and her colleagues have filed a patent on their technique and are continuing to collaborate with the medical supply company, which is currently making plans to manufacture medicine patches made from kirigami films.

As well as patent pending the SkimuneTM test, the Newcastle University team have set up a company Alcyomics Limited which aims to take the technology forward to offer personalised medicine, enabling an individual to be tested for drug responses.

The case highlights concerns that a network of individual gene patents could threaten the future of personalized medicine and whole - genome sequencing by blocking companies and clinicians from reporting a patient's genetic risk factors for different diseases.

ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine

San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative medicine company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty fcompany focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty fCompany was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty foreign.

Cross posted from Spoonful of Medicine The US Patent and Trademark Office granted its first license related to induced pluripotent stem (iPS) cells to a California biotech, Fate Therapeutics, the company announced today.

For personalized medicine companies like Optimal Medicine Ltd., the patents are about protecting billions of dollars invested in years of rmedicine companies like Optimal Medicine Ltd., the patents are about protecting billions of dollars invested in years of rMedicine Ltd., the patents are about protecting billions of dollars invested in years of research.

However, since a diet can not be patented, mainstream medicine has instead focused on pharmaceutical drugs and vaccines to combat diseases like Alzheimer's, as such drugs are seen as a financial windfall for pharmaceutical companies, with so many Americans in the «Baby Boomer» age group entering into their senior years.

McGill (played by Clooney as if Clark Gable were a patent medicine salesman) doesn't much want company on his escape, but since he is chained to the other two, he has no choice.

In «EU Implementing Compulsory Drug License Regime for Exports,» Bill Heinze writes, «The European Union will allow companies in the EU to apply for a license to manufacture, without the authorization of the patent holder, pharmaceutical products for export to countries in need of medicines and facing public health problems.

If you change any of those variables by allowing generics to enter in faster or through the Patented Medicine Price Review Board (PMPRB), they affect the ability of any company in the sector to receive financing, he says.

On the cost efficiency — or not — of our health system, an interesting article by Australian researchers was published by The Conversation explaining the concept of patent «evergreening» — a strategy pharmaceutical companies use to keep the cost of medicines (and their profits) high.